{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T17:15:46Z","timestamp":1648746946477},"reference-count":36,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.lpm.2008.06.013","type":"journal-article","created":{"date-parts":[[2008,9,7]],"date-time":"2008-09-07T14:54:44Z","timestamp":1220799284000},"page":"1538-1546","source":"Crossref","is-referenced-by-count":3,"title":["Hypothyro\u00efdie fruste et qualit\u00e9 de vie chez des femmes hypercholest\u00e9rol\u00e9miques de plus de 50 ans"],"prefix":"10.1016","volume":"37","author":[{"given":"Jacques","family":"Lecl\u00e8re","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Cousty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Louis","family":"Schlienger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Louis","family":"W\u00e9meau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2008.06.013_bib1","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1515\/CCLM.2004.136","article-title":"Establishment of a serum thyroid stimulating hormone (TSH) reference interval in healthy adults. The importance of environmental factors, including thyroid antibodies","volume":"42","author":"Jensen","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.lpm.2008.06.013_bib2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1515\/CCLM.2005.017","article-title":"Reference intervals for serum thyrotropin (TSH) in adults using the Access Immunotech System","volume":"43","author":"D\u2019Herbomez","year":"2005","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.lpm.2008.06.013_bib3","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1089\/105072502761016458","article-title":"Epidemiology and prevention of clinical and subclinical hypothyroidism","volume":"12","author":"Vanderpump","year":"2002","journal-title":"Thyroid"},{"key":"10.1016\/j.lpm.2008.06.013_bib4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00005650-199303000-00006","article-title":"The MOS 36-item Short-Form health survey (SF-36) II: Psychometric and clinical tests of validity in measuring physical and mental health constructs","volume":"31","author":"McHorney","year":"1993","journal-title":"Medical Care"},{"key":"10.1016\/j.lpm.2008.06.013_bib5","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1365-2265.2005.02381.x","article-title":"Instruments used in measuring symptoms, health status, and quality of life in hypothyroidism: a systematic quality review","volume":"63","author":"Razvi","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.lpm.2008.06.013_bib6","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1089\/thy.2005.15.1035","article-title":"Optimal thyrotropin level: normal ranges and reference intervals are not equivalent","volume":"15","author":"Dickey","year":"2005","journal-title":"Thyroid"},{"key":"10.1016\/j.lpm.2008.06.013_bib7","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1530\/eje.1.02136","article-title":"Is there a need to redefine the upper normal limit of TSH?","volume":"154","author":"Brabant","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.lpm.2008.06.013_bib8","unstructured":"Lepl\u00e8ge A, Ecosse E, Pouchot J, Coste J, Perneger T. Le questionnaire MOS SF-36. Manuel de l\u2019utilisateur et guide d\u2019interpr\u00e9tation des scores. Edition Estem, 2001, Paris."},{"key":"10.1016\/j.lpm.2008.06.013_bib9","first-page":"155","article-title":"The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community","volume":"6","author":"Vanderpump","year":"1996","journal-title":"Thyroid"},{"key":"10.1016\/j.lpm.2008.06.013_bib10","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/archinte.160.4.526","article-title":"The Colorado thyroid disease prevalence study","volume":"160","author":"Canaris","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.lpm.2008.06.013_bib11","first-page":"583","article-title":"Thyroid disease in the elderly. Part 2. Predictability of subclinical hypothyroidism","volume":"38","author":"Bemben","year":"1994","journal-title":"J Fam Pract"},{"key":"10.1016\/j.lpm.2008.06.013_bib12","first-page":"501","article-title":"Factors of variation and reference values for TSH in 45\u201370 year old women","volume":"61","author":"Steinmetz","year":"2000","journal-title":"Presse Med"},{"key":"10.1016\/j.lpm.2008.06.013_bib13","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1046\/j.1365-2265.1996.739560.x","article-title":"Effect of thyroid substitution on hypercholesterolaemia in patients with subclinical hypothyroidism: a reanalysis of intervention studies","volume":"44","author":"Tanis","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.lpm.2008.06.013_bib14","first-page":"57","article-title":"Fr\u00e9quence de l\u2019hypothyro\u00efdie dans une population de sujets hyperlipid\u00e9miques","volume":"22","author":"Bruckert","year":"1993","journal-title":"Presse Med"},{"key":"10.1016\/j.lpm.2008.06.013_bib15","first-page":"398","article-title":"Evaluation \u00e9conomique de l\u2019int\u00e9r\u00eat du diagnostic et de la prise en charge pr\u00e9coce de l\u2019hypothyro\u00efdie devant une hypercholest\u00e9rol\u00e9mie","volume":"60","author":"Henne","year":"1999","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.lpm.2008.06.013_bib16","doi-asserted-by":"crossref","first-page":"270","DOI":"10.7326\/0003-4819-132-4-200002150-00004","article-title":"Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study","volume":"132","author":"Hak","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2008.06.013_bib17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s11886-004-0054-3","article-title":"Hypothyroidism and dyslipidemia: modern concepts and approaches","volume":"6","author":"Pearce","year":"2004","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.lpm.2008.06.013_bib18","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/BF03347530","article-title":"The effect of Lthyroxine replacement therapy on lipid based cardiovascular risk in subclinical hypothyroidism","volume":"27","author":"Serter","year":"2004","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.lpm.2008.06.013_bib19","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1210\/jc.86.10.4860","article-title":"TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study)","volume":"86","author":"Meier","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2008.06.013_bib20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1055\/s-2004-835372","article-title":"Hypothyroidism and cardiovascular disease: role of new risk factors and coagulation parameters","volume":"4","author":"Jublanc","year":"2004","journal-title":"Semin Vasc Med"},{"key":"10.1016\/j.lpm.2008.06.013_bib21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1081\/ERC-200033558","article-title":"Homocysteine concentrations in subclinical hypothyroidism","volume":"30","author":"Sengul","year":"2004","journal-title":"Endocr Res"},{"key":"10.1016\/j.lpm.2008.06.013_bib22","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.metabol.2004.05.016","article-title":"Emerging cardiovascular risk factors in subclinical hypothyroidism: lack of change after restoration of euthyroidism","volume":"53","author":"Perez","year":"2004","journal-title":"Metabolism"},{"key":"10.1016\/j.lpm.2008.06.013_bib23","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0021-9150(02)00372-6","article-title":"Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial","volume":"166","author":"Christ-Crain","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.lpm.2008.06.013_bib24","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1210\/jc.2003-031669","article-title":"Effect of levothyroxine replacement on lipid profile and intimamedia thickness in subclinical hypothyroidism: a double-blind, placebo- controlled study","volume":"89","author":"Monzani","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2008.06.013_bib25","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1210\/jc.2003-030039","article-title":"Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy","volume":"88","author":"Taddei","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2008.06.013_bib26","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1089\/105072502760143890","article-title":"Subclinical hypothyroidism and cardiac function","volume":"12","author":"Biondi","year":"2002","journal-title":"Thyroid"},{"key":"10.1016\/j.lpm.2008.06.013_bib27","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1210\/jc.86.3.1110","article-title":"Effect of levothyroxine on cardiac function and structure in subclinical hypothyroidism: a double blind, placebo-controlled study","volume":"86","author":"Monzani","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2008.06.013_bib28","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jacc.2004.10.044","article-title":"Does subclinical hypothyroidism affect cardiac pump performance? Evidence from a magnetic resonance imaging study","volume":"45","author":"Ripoli","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.lpm.2008.06.013_bib29","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0140-6736(78)91645-8","article-title":"Can the initial clinical assessment of thyroid function be improved?","volume":"2","author":"White","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2008.06.013_bib30","first-page":"505","article-title":"Evolution \u00e0 trois ans de 97 cas d\u2019hypothyro\u00efdie fruste. Suivi d\u2019une cohorte de femmes de 45 \u00e0 70 ans examin\u00e9es dans les Centres d\u2019Examens de Sant\u00e9","volume":"63","author":"Steinmetz","year":"2002","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.lpm.2008.06.013_bib31","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1210\/jc.2003-032061","article-title":"Spontaneous subclinical hypothyroidism in patients older than 55 years: An analysis of natural course and risk factors for the development of overt thyroid failure","volume":"89","author":"D\u00edez","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2008.06.013_bib32","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2006-1869","article-title":"The beneficial effect of L-Thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial","volume":"92","author":"Razvi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2008.06.013_bib33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1258\/000456307780480945","article-title":"Thyroid guidelines \u2013 are thyroid-stimulating hormone assays fit for purpose?","volume":"44","author":"Beckett","year":"2007","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.lpm.2008.06.013_bib34","first-page":"367","article-title":"Subclinical hypothyroidism neurobehavioural features and beneficial effect of L-thyroxine treatment","volume":"71","author":"Monzani","year":"1993","journal-title":"Clin Investig"},{"key":"10.1016\/j.lpm.2008.06.013_bib35","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0002-9343(02)01022-7","article-title":"A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism","volume":"112","author":"Kong","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.lpm.2008.06.013_bib36","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/thy.2006.0252","article-title":"Health status, psychological symptoms, mood, and cognition in l-thyroxine-treated hypothyroid subjects","volume":"17","author":"Samuels","year":"2007","journal-title":"Thyroid"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498208004351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498208004351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,25]],"date-time":"2018-12-25T22:27:33Z","timestamp":1545776853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498208004351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0755498208004351"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2008.06.013","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}